TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 135 filers reported holding TG THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $319 | -99.4% | 21,224 | +74.1% | 0.03% | +750.0% |
| Q2 2022 | $52,000 | -73.5% | 12,191 | -40.7% | 0.00% | -73.3% |
| Q1 2022 | $196,000 | -22.2% | 20,565 | +216.7% | 0.02% | -37.5% |
| Q2 2021 | $252,000 | -72.1% | 6,493 | -62.5% | 0.02% | -75.3% |
| Q4 2020 | $902,000 | +342.2% | 17,330 | +65.4% | 0.10% | +304.2% |
| Q2 2020 | $204,000 | -43.5% | 10,477 | -67.8% | 0.02% | -31.4% |
| Q4 2019 | $361,000 | +423.2% | 32,551 | +165.2% | 0.04% | +600.0% |
| Q3 2019 | $69,000 | -67.3% | 12,273 | -76.2% | 0.01% | -54.5% |
| Q4 2018 | $211,000 | +263.8% | 51,570 | +399.5% | 0.01% | +175.0% |
| Q3 2018 | $58,000 | -88.8% | 10,325 | -71.8% | 0.00% | -85.7% |
| Q1 2018 | $520,000 | +37.6% | 36,592 | -20.5% | 0.03% | +40.0% |
| Q4 2017 | $378,000 | +58.8% | 46,055 | +129.0% | 0.02% | +66.7% |
| Q3 2017 | $238,000 | – | 20,112 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |